Abstract
Injection of Egyptian toads Bufo regularis, with adriamycin subcutaneously in the dorsal lymph sac at a dose level of 0.1 mg/toad, once every 3 weeks for 3 months induced pronounced alterations in the blood cells. These alterations were more or less similar to the criteria reported in human leukaemia. These changes were all comparable to those observed after the treatment of the experimental animals with the chemical carcinogen 7,12-dimethylbenz(a)anthracene. It is speculated that toads (Bufo regularis) can be used as biological test animals for screening chemicals or drugs which induce leukaemia in man.
Original language | English |
---|---|
Pages (from-to) | 657-660 |
Number of pages | 4 |
Journal | Oncology Reports |
Volume | 4 |
Issue number | 3 |
DOIs | |
Publication status | Published - 1997 |
Externally published | Yes |
Keywords
- 7,12-dimethylbenz(a)anthracine
- adriamycin
- Bufo regularis
- leukaemia